Aloe Vera

Names and identification

Language	Name
English	aloe vera
Latin/Botanical	Aloe barbadensis Mill. (syn. Aloe vera (L.) Burm.f.)

How does it work?

• Acemannan (primary bioactive polysaccharide) activates innate immune cells (macrophages, dendritic cells) producing IL-1, IL-6, IL-12, TNF-alpha, colony-stimulating factors, and stem cell factors.
• Acemannan induces IL-12 release, triggering natural killer cell activation and T cell proliferation/activation (adaptive immune response).
• Breakage of acemannan chains into smaller fragments enhances biological effects; fragments boost vaccine efficacy via mannose receptor agonism of macrophages/dendritic cells.
• Wound healing: activated macrophage cytokines (IL-1, IL-6, TNF-alpha) promote robust fibroblast proliferation and collagen synthesis.
• Acemannan/chitosan combinations accelerate wound closure by promoting granular tissue formation.
• Aloe-emodin and other anthraquinones exhibit antiproliferative and proapoptotic effects on cancer cell lines.
• Barbaloin acts as a stimulant laxative by increasing colonic motility and water/electrolyte secretion.

What do recent clinical trials show?

• Sadoyu S, Rungruang C, Wattanavijitkul T and others 2021. Aloe vera and health outcomes: An umbrella review of systematic reviews and meta-analyses. Phytotherapy research : PTR. PMID 32924222 · doi:10.1002/ptr.6833
  Of 71 unique outcomes reviewed, 47 (67%) were nominally statistically significant, but only 3 outcomes supported by highly suggestive evidence (prevention of second-degree infusion phlebitis, chemotherapy-induced mucositis), while 42 outcomes had weak evidence.
• Catalano A, Ceramella J, Iacopetta D and others 2024. Aloe vera-An Extensive Review Focused on Recent Studies. Foods (Basel, Switzerland). PMID 38998660 · doi:10.3390/foods13132155
  Updated review documenting broad spectrum of pharmacological activities with focus on recent clinical and preclinical evidence for therapeutic applications.

4 further claims previously listed here could not be traced to a published paper and have been removed. An absence here means we could not identify the source, not that no work exists.

Recent safety updates

• 48 known moderate drug interactions documented (Drugs.com interaction checker).
• Hepatotoxicity concern: 22 reported cases of liver injury attributed to Aloe vera preparations (17 women, 5 men, mean age 50). Hepatocellular injury most common manifestation (86.3%). Latency 3-24 weeks.
• Alkaloids in aloe vera enhance hepatic enzymes and alcohol dehydrogenase activity, potentially interfering with detoxification mechanisms.
• Oral ingestion associated with diarrhea, hypokalemia, pseudomelanosis coli, and kidney failure.
• Topical use may cause phototoxicity and hypersensitive reactions in susceptible individuals.
• Anthraquinone-containing latex (aloin) is a potent laxative; chronic use may cause electrolyte imbalance and dependency.
• Herbal/dietary supplements implicated in 19% of drug-induced acute liver failure cases; Aloe vera is among recognized causes.
• Avoid during pregnancy (potential uterine stimulant effects) and breastfeeding.

Dosage forms and preparation

Dosage Forms: Swarasa (fresh gel juice), Kumari Asava (fermented preparation), Capsule (freeze-dried gel), Tablet, Topical gel, Ghrita (medicated ghee), Churna (dried powder)

Standard Dosage: 15-30ml fresh juice twice daily; 15-30ml Kumaryasava after meals; 300-500mg dried extract capsule; topical gel application as needed

Bioavailability: Acemannan (primary polysaccharide) has limited oral bioavailability but significant immunomodulatory action in the gut (Peyer’s patches). Anthraquinone glycosides (aloin A/B) have good oral absorption and undergo colonic bacterial metabolism to active aglycones. Aloe-emodin reaches peak plasma levels in 6-8 hours. Fresh gel matrix enhances absorption of co-administered nutrients. Decolorized inner fillet gel has better tolerability profile.

Optimal Timing: Fresh juice early morning on empty stomach for detox/digestive health. Kumaryasava after meals. Topical gel as needed. Avoid during pregnancy (uterine stimulant effect of anthraquinones).

Standardized Extract: Inner fillet gel: standardized to minimum 10% acemannan (dry weight), aloin < 10ppm. Whole leaf extract: standardized to 20% aloin (laxative grade). 200:1 freeze-dried gel concentrate.

Shelf Life: 2 days (fresh gel, refrigerated); 2 years (freeze-dried powder); 3 years (capsules/tablets); 5 years (Kumaryasava); 1 year (preserved liquid gel)

Storage: Fresh gel: refrigerated 2-8°C, use within 48 hours. Dried extracts: cool, dry place below 25°C, airtight containers. Liquid products: avoid direct sunlight, store below 25°C. Kumaryasava: room temperature in amber glass.

Marker Compounds: Acemannan, Aloin A (barbaloin), Aloin B (isobarbaloin), Aloe-emodin, Aloesin, Beta-sitosterol, Glucomannans

Extraction Methods

• Cold stabilization of fresh inner fillet gel (no heating above 40°C)
• Freeze-drying for powder (200:1 concentration ratio)
• Spray-drying with maltodextrin carrier
• Charcoal filtration for decolorized (low-anthraquinone) gel
• Ethanol precipitation for acemannan isolation

Synergistic Combinations

• With Haridra (turmeric) for wound healing and anti-inflammatory action
• With Kumari + Guduchi in Kumaryasava for liver and uterine health
• With Shatavari for female reproductive health
• With Ghrita (ghee) for Pitta pacification and internal lubrication
• With Amalaki for digestive tract healing